BNIG.F Stock Overview
Develops and sells smoking control products, air purifiers, water filters, cosmetics, stem-cell therapies, and health care products and supplements in Australia and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Beroni Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.82 |
| 52 Week High | AU$9.64 |
| 52 Week Low | AU$0.25 |
| Beta | 0.14 |
| 11 Month Change | 0% |
| 3 Month Change | 15.49% |
| 1 Year Change | -88.61% |
| 33 Year Change | -18.00% |
| 5 Year Change | n/a |
| Change since IPO | -88.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| BNIG.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | -3.0% | 0.9% |
| 1Y | -88.6% | 19.2% | 32.4% |
Return vs Industry: BNIG.F underperformed the US Biotechs industry which returned 13.1% over the past year.
Return vs Market: BNIG.F underperformed the US Market which returned 14.1% over the past year.
Price Volatility
| BNIG.F volatility | |
|---|---|
| BNIG.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 10.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: BNIG.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BNIG.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Jacky Zhang | www.beronigroup.com |
Beroni Group Limited, together with its subsidiaries, develops and sells smoking control products, air purifiers, water filters, cosmetics, stem-cell therapies, and health care products and supplements in Australia and internationally. It operates through Nicobloc, Fogibloc Air Purifier, Olansi Water Filter, Health Supplements, Cosmetic Products, and Viral Diagnostic Kits segments. The company’s products include NicoBloc, a smoking cessation/harm reduction product; and Fogibloc, an air purifier system.
Beroni Group Limited Fundamentals Summary
| BNIG.F fundamental statistics | |
|---|---|
| Market cap | US$59.97m |
| Earnings (TTM) | -US$7.80m |
| Revenue (TTM) | US$916.00k |
0.0x
P/S Ratio0.0x
P/E RatioIs BNIG.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BNIG.F income statement (TTM) | |
|---|---|
| Revenue | AU$916.00k |
| Cost of Revenue | AU$0 |
| Gross Profit | AU$916.00k |
| Other Expenses | AU$8.71m |
| Earnings | -AU$7.80m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.34 |
| Gross Margin | 100.00% |
| Net Profit Margin | -851.20% |
| Debt/Equity Ratio | 158.4% |
How did BNIG.F perform over the long term?
See historical performance and comparison